US OptionsDetailed Quotes

NRXP250117C10000

Watchlist
  • 0.00
  • 0.000.00%
15min DelayClose Jan 24 09:30 ET
0.00High0.00Low
Intraday
  • 5D
  • Daily

No Data

Comments

    $NRX Pharmaceuticals (NRXP.US)$
    NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement
    Tuesday, 21st January at 8:02 am
    • Company received written notice from the Nasdaq Listing Qualifications Staff stating that the Company regained compliance with the applicable Nasdaq minimum market value of listed securities continued listing requirement
    • Nasdaq stated that the matter is now closed
    WILMINGTON, Del., Jan. 21, 2025 /PR...
    $NRX Pharmaceuticals (NRXP.US)$
    FDA Approval scheduled on June 30th 2025
    FDA Calendar – FDA Tracker
    $NRX Pharmaceuticals (NRXP.US)$
    HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel
    Tuesday, 14th January at 8:03 am
    "'Special K': The Science & Stigma of Ketamine" on CNN, hosted by Dr. Sanjay Gupta
    David Feifel MD PHD, Founder of Kadima, is a global thought leader in the interventional psychiatry field
    Kadima Neuropsychiatry Institute identified as p...
    $NRX Pharmaceuticals (NRXP.US)$ Reuters· 1 min ago
    NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announces It Has Filed an Application With Nasdaq to Uplist to the Nasdaq Global Market From the Nasdaq Capital Market
    $NRX Pharmaceuticals (NRXP.US)$
    NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces it has Filed an Application with NASDAQ to Uplist to the NASDAQ Global Market from the NASDAQ Capital Market
    Monday, 13th January at 8:04 am
    • Management believes uplisting has the potential to provide shareholders with improved liquidity
    • Requires NRx Pharmaceuticals to meet certain listing requirements
    • Company has advised NASDAQ that current shares outstanding is 15.7 million
    WILMINGTON, Del., Jan. 13, 2...
Read more